The mid-cap momentum
The mid-cap momentum
About this video
Key points:
Mid-cap equities viewed as optimal for risk-adjusted returns
Under-researched nature presents opportunities for active management
Life360 (ASX:360), Imdex (ASX:IMD), JB Hi-Fi (ASX:JBH), Iress (ASX:IRE), and Ryman Healthcare (ASX:RYM) identified as notable stocks
Extensive fundamental analysis and site visits drive stock selection
Australian mid-cap equities are attracting increased attention, according to Jack Briggs from Ellerston Capital, who identifies this segment as a compelling opportunity for risk-adjusted returns. Briggs contends that mid caps offer proven business models with growth potential, unlike large caps which lack market share gains and excitement, or small caps which often face governance concerns and reliance on external capital. He points to historic outperformance of the Midcap 50 Index over large caps and significant gains against the Small Ordinaries Index.
Briggs highlights the under-researched nature of mid caps as a notable advantage, allowing for deeper analysis and the potential to identify mispriced opportunities. His investment approach at Ellerston Capital involves comprehensive research, including site visits and competitor checks, to develop a differentiated outlook. Key examples in his portfolio include JB Hi-Fi (ASX:JBH), which he regards as a prime candidate following in-store observations, and Life360 (ASX:360), where he sees upside from the recently launched pet tracker and future advertising revenue, underpinned by a large US user base.
Discussing turnaround stories, Briggs singles out Imdex (ASX:IMD) and Iress (ASX:IRE) as stocks identified through cyclical and execution-driven analysis. He also notes Ryman Healthcare (ASX:RYM), recently listed in Australia, as a mixed turnaround play following in-depth research on the ground in New Zealand.